Widespread neuronal ectopia associated with secondary defects in cerebrocortical chondroitin sulfate proteoglycans and basal lamina in MARCKS- deficient mice

Experimental Neurology

Volumn 145, Issue 1, 1997, Pages 46-61

  Blackshear, Perry J ^a   Silver, Jerry ^b   Nairn, Angus C ^c   Sulik, Kathleen K ^d   Squier, Marion V ^e   Stumpo, Deborah J ^a   Tuttle, Jane S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MARCKS PROTEIN; PROTEOCHONDROITIN SULFATE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BRAIN DEVELOPMENT; CELL MIGRATION; DEVELOPMENTAL DISORDER; ECTOPIC TISSUE; FOREBRAIN; MOUSE; NERVOUS TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DEFICIENCY;

EID: 0031149411     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6475     Document Type: Article

References (52)

1. Aderem A. The MARCKS brothers: A family of protein kinase C substrates. Cell. 71:1992;713-716.
2. Angevine J. B., Sidman R. L. Autoradiographic study of cell migration during histogenesis of cerebral cortex in the mouse. Nature. 192:1961;766-768.
3. Avnur Z., Geiger G. Immunocytochemical localization of native chondroitin-sulfate in tissues and cultured cells using a specific monoclonal antibody. Cell. 38:1984;811-822.
4. Bicknese A. R., Sheppard A. M., O'Leary D. D., Pearlman A. L. Thalamocortical axons extend along a chondroitin sulfate proteoglycan-enriched pathway coincident with the neocortical subplate and distinct from the efferent path. J. Neurosci. 14:1994;3500-3510.
5. Blackshear P. J. The MARCKS family of cellular protein kinase C substrates. J. Biol Chem. 268:1993;1501-1504.
6. Blackshear P. J., Tuttle J. S., Oakey R. J., Seldin M. F., Chery M., Philippe C., Stumpo D. J. Chromosomal mapping of the muman (MACSMacs. Genomics. 14:1992;168-174.
7. Blackshear P. J., Lai W. S., Tuttle J. S., Stumpo D. J., Kennington E., Nairn A. C., Sulik K. K. Developmental expression of MARCKS and protein kinase C in mice in relation to the exencephaly resulting from MARCKS deficiency. Dev. Brain Res. 96:1996;62-75.
8. Buck M. R., Karustis D. G., Day N. A., Honn K. V., Sloane B. F. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochemistry. 282:1992;273-278.
9. Choi B. H. Role of the basement membrane in neurogenesis and repair of injury in the central nervous system. Microsc. Tes. Techn. 28:1994;193-203.
10. Choi B. H., Matthias S. Cortical dysplasia associated with massive ectopia of neurons and glial cells within the subarachnoid space. Acta Neuropathol. 73:1987;105-109.
11. D'Amato C. J., O'Shea K. S., Hicks S. P., Glover R. A., Annesley T. M. Genetic prenatal aqueductal stenosis with hydrocephalus in rat. J. Neuropathol. Exp. Neurol. 45:1986;665-682.
12. D'Arcangelo G., Miao G. G., Chen S-C., Soares H. D., Morgan J. I., Curran T. A protein resembling extracellular matrix proteins deleted in the mouse mutantreeler. Nature. 374:1995;719-723.
13. Del Rio J. A., Soriano E., Ferrer I. Development of GABA-immunoreactivity in the neocortex of the mouse. J. Comp. Neurol. 326:1992;501-526.
14. Dobyns W. B., Pagon R. A., Armstrong D., Curry C. J. R., Greenberg F., Grix A., Holmes L. B., Laxova R., Michels V. V., Robinow M., Zimmerman R. L. Diagnostic criteria for Walker-Warburg syndrome. Am. J. Med. Genet. 35:1989;195-210.
15. Friedlander D., Milev P., Karthikeyan L., Margolis R. K., Margolis R. U., Grumet M. The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM and inhibits neuronal adhesion and neurite outgrowth. J. Cell Biol. 125:1994;669-680.
16. Fukuyama Y., Osawa M., Suzuki H. Congenital progressive muscular dystropy of the Fukuyama type-clinical, genetic and pathological considerations. Brain Dev. 3:1981;1-29.
17. Galaburda A. M., Rosen G. D., Sherman G. F. The neural origin of developmental dyslexia: Implications for medicine, neurology and cognition. From Reading to Neurons. 1989;MIT Press, Cambridge. p. 377-388.
18. Goffinet A. M. An early developmental defect in the cerebral cortex of the reeler mouse - A morphological study leading to a hypothesis concerning the action of the mutant gene. Anat. Embroyol. 157:1979;205-216.
19. Gordon H., Sweets H. H. A simple method for the silver impregnation of reticulum. Am. J. Pathol. 12:1936;545.
20. Harlan D. M., Graff J. M., Stumpo D. J., Eddy R. L. Jr., Shows T. B., Boyle J. M., Blackshear P. J. The human myristoylated alanine-rich C kinase substrate (MARCKS) gene (MACS. J. Biol. Chem. 266:1991;14399-14405.
21. Jahn R., Schiebler W., Ouimet C., Greengard P. A 38,000 dalton membrane protein (p38) present in synaptic vesicles. Proc. Natl. Acad. Sci. USA. 82:1985;4137-4141.
22. LaMantia A. S., Colbert M. C., Linney E. B. Retinoic acid induction and regional differentiation prefigure olfactory pathway formation in the mammalian forebrain. Neuron. 10:1993;1035-1048.
23. McConnell S. K. The specification of neuronal identity in the mammalian cerebral cortex. Experientia. 46:1990;922-929.
24. Meyer-Puttlitz B., Junker E., Margolis R. M., Margolis R. K. Chrondoitin sulfate proteoglycans in the developing central nervous system. II. Immunocytochemical localization of neurocan and phosphacan. J. Comp. Neurol. 366:1996;44-55.
25. Milev P., Friedlander D. R., Sakurai T., Karthikeyan L., Flad M., Margolis R. K., Grumet M., Margolis R. U. Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules. J. Cell Biol. 127:1994;1703-1715.
26. Ming P., Holzgreve W., Horst J. Genetic factors in lissencephaly syndromes: a review. Child's Nerv. Sys. 9:1993;413-417.
27. Misson J. P., Edwards M. A., Yamamoto M., Caviness V. S. Identification of radial glial cells within the developing murine central nervous system: Studies based upon a new histochemical marker. Dev. Brain Res. 44:1988;94-108.
28. Oohira A., Matsui F., Katoh-Semba R. Effects of brain chondroitin sulfate proteoglycans on neurite outgrowth from PC12 cells. J. Neurosci. 11:1991;822-827.
29. O'Shea K. S., Rheinheimer J. S. T., D'Amato C. J., Hicks S. P. Alterations in the neuroepithelial basal lamina in a neurological mutant with prenatal hydrocephalus. J. Neuropathol. Exp. Neurol. 47:1988;507-515.
30. Perriss R., Johansson S. Inhibition of neural crest stem cell migration by aggregating chondroitin sulfate proteoglycans is mediated by their hyaluron-binding region. Dev. Biol. 137:1990;1-12.
31. Rakic P. Principles of neuronal cell migration. Experientia. 46:1990;882-891.
32. Romanic A. M., Madri J. A. Extracellular matrix-degrading proteinases in the central nervous system. Brain Pathol. 4:1994;145-156.
33. Santavuori P., Somer H., Sainio K., Rapola J., Kruus S., Nikitin T., Ketonen L., Leisti J. Muscle-eye-brain disease (MEB). Brain Dev. 11:1984;147-153.
34. Sarnat H. B. Cerebral Dysgenesis. Embryology and Clinical Expression. 1992;Oxford Univ. Press, Oxford. p. 245-274.
35. Schrott L. M., Waters N. S., Boehm G. W., Sherman G. F., Morrison L., Rosen G. D., Behan P. O., Galaburda A. M., Denenberg V. H. Behavior, cortical ectopias, and autoimmunity in BXSB - Yaa and BXSB - Yaat mice. Brain Behav. Immun. 7:1993;205-223.
36. Seeds N. W., Haffke S., Christensen K., Schoonmaker J. Cerebellar granule cell migration involves proteolysis. Adv. Exp. Med. Biol. 265:1990;169-178.
37. Sheppard A. M., Hamilton S. K., Pearlman A. L. Changes in the distribution of extracellular matrix components accompany early morphogenetic events of mammalian cortical development. J. Neurosci. 11:1991;3928-3942.
38. Sherman G. F., Galaburda A. M., Geschwind N. Cortical anomalies in the brains of New Zealand mice: A neuropathologic model of dyslexia. Proc. Natl. Acad. Sci. USA. 82:1985;8072-8074.
39. Sherman G. F., Morrison L., Rosen G. D., Behan P. O., Galaburda A. M. Brain abnormalities in immune defective mice. Brain Res. 532:1990;25-33.
40. Sherman G. F., Stone L. V., Denenberg V. H., Beier D. R. A genetic analysis of neocortical ectopias in New Zealand Black autoimmune mice. NeuroReports. 5:1994;721-724.
41. Snow D. M., Lemmon V., Carrino D. A., Caplan A. I., Silver J. Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowthin vitro. Exp. Neurol. 109:1990;111-130.
42. Sorrell J. M., Carrino D. A., Caplan A. I. Structural domains in chondroitin sulfate identified by anti-chondroitin sulfate monoclonal antibodies. Immunosequencing of chondroitin sulfates. Matrix. 13:1993;351-361.
43. Spizz G., Blackshear P. J. Protein kinase C-mediated phosphorylation of the myristoylated alanine-rich C-kinase substrate protects it from specific proteolytic cleavage. J. Biol. Chem. 271:1996;553-562.
44. Squier M. V. Fetal type II lissencephaly: a case report. Child's Nerv. Sys. 9:1993;400-402.
45. Stumpo D. J., Bock C. B., Tuttle J. S., Blackshear P. J. MARCKS deficiency in mice leads to abnormal brain development and perinatal death. Proc. Natl. Acad. Sci. USA. 92:1995;944-948.
46. Sudhof T. C., Jahn R. Proteins of synaptic vesicles involved in exocytosis and membrane recycling. Neuron. 6:1991;665-677.
47. Swierczynski S. L., Siddhanti S. R., Tuttle J. S., Blackshear P. J. Nonmyristoylated MARCKS complements some but not all of the developmental defects associated with MARCKS deficiency in mice. Dev. Biol. 179:1996;135-147.
48. Toda T., Ikegawa S., Okui K., Kondo E., Saito K., Fukuyama Y., Yoshioka M., Kumagai T., Suzumori K., Kanazawa I., Nakamura Y. Refined mapping of a gene responsible for Fukuyama-Type congenital muscular dystrophy: Evidence for strong linkage disequilibrium. Am. J. Hum. Genet. 55:1994;946-950.
49. Toda T., Segawa M., Nomura Y., Nonaka I., Masuda K., Ishihara T., Sakai M., Tomita I., Origuchi Y., Ohno K., Misugi N., Sasaki Y., Takada K., Kawai M., Otani K., Murakami T., Saito K., Fukuyama Y., Shimizu G., Kanazawa I., Nakamura Y. Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nature Genet. 5:1993;283-286.
50. r. Cell. 41:1985;1017-1028.
51. Wisniewski K., Dambska M., Sher J. H., Qazi Q. A clinical neuropathological study of the fetal alcohol syndrome. Neuropediatrics. 14:1983;197-201.
52. Yuasa S., Kitoh J., Oda S., Kawamura K. Obstructed migration of Purkinje cells in the developing cerebellum of the reeler mutant mouse. Anat. Embryol. 188:1993;317-329.